Breast Cancer PubMed (@breastoncpubmed) 's Twitter Profile
Breast Cancer PubMed

@breastoncpubmed

Summarizes latest clinical findings from 350+ selected journals. #BreastCancer #BreastOncology #TripleNegativeBreastCancer #HER2 #ERBB2 #PubXelProject

ID: 1914826347458793472

linkhttps://pubxel.org calendar_today22-04-2025 23:39:17

27 Tweet

13 Takipçi

139 Takip Edilen

Breast Cancer PubMed (@breastoncpubmed) 's Twitter Profile Photo
Breast Cancer PubMed
@breastoncpubmed

2 months ago

.ESMO Open Prospective study (n=95). Tumor-agnostic methylation-based MRD (mMRD) for early-stage BC showed superior prognostic value (HR 17.0, P<0.0001) vs genomic MRD, with 62.5% sensitivity and 100% specificity for recurrence. PMID:40472659 pubmed.ncbi.nlm.nih.gov/40472659/